The Challenges of Precision Oncology Drug Development and Implementation

Publisher： Karger

E-ISSN： 1662-8063|18|6|338-348

ISSN： 1662-4246

Source： Public Health Genomics, Vol.18, Iss.6, 2015-0, pp. : 338-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Tensions and Challenges of Unpredictable Drug Shortages

By Goodman Annekathryn  

American Journal of Bioethics, Vol. 12, Iss. 1, 2012-01 ,pp. : 20-22

Routledge Ltd

Access to resources Recommend Favorite

Pharmacogenetics: implications for drug development, patients and society

By McCarthy Alun  

New Genetics & Society, Vol. 19, Iss. 2, 2000-08 ,pp. : 135-143

Routledge Ltd

Access to resources Recommend Favorite

European Reference Networks and Guideline Development and Use: Challenges and Opportunities

By  

Public Health Genomics, Vol. 18, Iss. 5, 2015-0 ,pp. : 318-320

Karger

Access to resources Recommend Favorite

Challenges and Solutions in the Development of Genomic Biomarker Panels: A Systematic Phased Approach

By  

Current Genomics, Vol. 13, Iss. 4, 2012-06 ,pp. : 334-341

Bentham Science Publishers

Access to resources Recommend Favorite

Virtual Clinical Trials, an Essential Step in Increasing the Effectiveness of the Drug Development Process

By  

Public Health Genomics, Vol. 18, Iss. 6, 2015-0 ,pp. : 366-371

Karger

Access to resources Recommend Favorite